Treatment of Pruritus in Flucloxacillin-Induced Liver Injury
For cholestatic pruritus from flucloxacillin-induced liver injury with elevated bilirubin, start with cholestyramine 4g up to four times daily as first-line therapy, followed by rifampicin 150-600mg daily if cholestyramine fails or is not tolerated 1, 2.
Stepwise Treatment Algorithm
First-Line: Cholestyramine
- Dose: 4g up to four times daily 1
- Mechanism: Binds bile acids in the intestine, interrupting enterohepatic circulation 2
- Critical timing: Space at least 4 hours away from any other medications to prevent binding interactions 1
- Efficacy: Established as first-line with moderate evidence, though efficacy can be marginal in some patients 1, 2
- Limitation: Poor palatability and gastrointestinal side effects may limit tolerability
Second-Line: Rifampicin
- Starting dose: 150mg daily with monitoring of liver function tests 1
- Titration: Increase stepwise (every other week) to maximum 600mg daily if needed 1
- Efficacy: Moderate to good efficacy for cholestatic pruritus 2
- Important consideration: A recent case report specifically demonstrated successful use of rifampicin monotherapy for persistent cholestatic jaundice and pruritus following flucloxacillin-induced liver injury, with gradual symptomatic improvement and declining bilirubin 3
- Monitoring: Serial liver function tests required due to potential hepatotoxicity 1
Third-Line: Naltrexone
- Starting dose: 25mg daily, titrating to 50mg daily 1
- Mechanism: Oral opioid antagonist
- Critical warning: Only consider after proven failure or intolerance to both cholestyramine and rifampicin 1
- Common pitfall: Can cause opioid withdrawal-like reactions on initiation; some protocols use IV naloxone induction to mitigate this 1
- Efficacy: Variable, with clinical experience often disappointing 1
Fourth-Line: Sertraline
- Dose: Up to 100mg daily 1, 2
- Mechanism: Selective serotonin reuptake inhibitor; exact mechanism for pruritus relief unclear 1
- Evidence: Small studies show improvement in itch scores (75-100mg/day well tolerated) 4, though clinical experience has been mixed 1
- Consider: When resistant to all above treatments 1
Treatments to Avoid
Do NOT use antihistamines (e.g., chlorpheniramine, alimemazine) - they have only marginal efficacy with sedative effects and are not recommended for cholestatic pruritus 1, 2. The pruritus mechanism in cholestasis is not histamine-mediated.
Do NOT use ondansetron or phenobarbital - lack of efficacy and excessive side-effect profile, respectively 1.
Special Considerations for Flucloxacillin-Induced Liver Injury
The flucloxacillin-induced hepatotoxicity typically presents within 45 days of exposure 5 and can cause persistent hepatocellular secretory failure even after drug discontinuation 3. In this specific context:
- Rifampicin has documented success: The case literature specifically supports rifampicin for persistent hyperbilirubinemia and pruritus following flucloxacillin withdrawal 3
- Monitor liver function closely: Flucloxacillin hepatotoxicity is usually reversible on discontinuation, but requires monitoring 6
- Consider earlier escalation to rifampicin: Given the specific case evidence in flucloxacillin-induced injury, if cholestyramine provides inadequate relief, move to rifampicin without prolonged delay
Invasive/Experimental Options
If all medical therapies fail and pruritus remains debilitating 1, 2:
- Extracorporeal albumin dialysis
- Plasmapheresis
- Bile duct drainage (if obstruction present)
- Liver transplantation (only when all other interventions ineffective)
Monitoring Response
Use a visual analogue scale (0-10) to quantify itch severity and track response to interventions 1.